TNF Pharmaceuticals, Inc.
TNFA
$0.0625
-$0.0126-16.78%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -70.82% | 238.97% | 73.03% | 25.60% | 12.38% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.72% | 23.87% | 0.06% | 9.62% | -14.80% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -64.11% | 175.56% | 61.82% | 23.53% | 9.24% |
|
|
|||||
| Total Current Assets | -64.11% | 175.56% | 61.82% | 23.53% | 9.24% |
| Net Property, Plant & Equipment | -- | -92.26% | -77.64% | -79.87% | -76.02% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -34.99% | 29.58% | 19.92% | 10.16% | 4.49% |
|
|
|||||
| Total Accounts Payable | -34.58% | -35.38% | -18.31% | 174.88% | 146.67% |
| Total Accrued Expenses | -- | -16.11% | -39.30% | -33.63% | 5.43% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -92.50% | -78.32% | -74.79% | -63.30% |
| Total Finance Division Other Current Liabilities | 151.91% | 2,990.11% | 209.79% | -21.71% | 463.49% |
| Total Other Current Liabilities | 151.91% | 2,990.11% | 209.79% | -21.71% | 463.49% |
| Total Current Liabilities | -4.02% | 24.30% | 34.35% | 22.70% | 138.06% |
|
|
|||||
| Total Current Liabilities | -4.02% | 24.30% | 34.35% | 22.70% | 138.06% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 79.26% |
| Total Liabilities | -78.65% | 16.13% | 31.69% | 22.26% | 89.14% |
|
|
|||||
| Common Stock & APIC | 12.74% | 13.73% | 21.52% | 26.85% | 11.49% |
| Retained Earnings | -8.54% | -16.02% | -26.63% | -29.78% | -23.36% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 11,091.01% | -12.73% | -21.10% | 8.31% | -100.44% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 1,407.74% | 1,082.32% | 824.99% | -43.94% | -52.61% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1,407.74% | 1,082.32% | 824.99% | -43.94% | -52.61% |
|
|
|||||
| Total Common Equity | 11,091.01% | -12.73% | -21.10% | 8.31% | -100.44% |
| Total Preferred Equity | 1,407.74% | 1,082.32% | 824.99% | -43.94% | -52.61% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2,934.53% | 35.16% | 15.24% | 5.87% | -96.68% |
|
|
|||||